ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 59 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $158,084 | -41.5% | 214,642 | 0.0% | 0.00% | – |
Q2 2023 | $270,449 | +73.1% | 214,642 | -0.4% | 0.00% | – |
Q1 2023 | $156,199 | +34.2% | 215,476 | -2.2% | 0.00% | – |
Q4 2022 | $116,399 | -36.4% | 220,244 | 0.0% | 0.00% | – |
Q3 2022 | $183,000 | -23.4% | 220,244 | +0.6% | 0.00% | – |
Q2 2022 | $239,000 | -81.0% | 218,959 | -78.3% | 0.00% | – |
Q1 2022 | $1,259,000 | -25.0% | 1,006,950 | -4.1% | 0.00% | – |
Q4 2021 | $1,679,000 | -52.4% | 1,049,488 | -3.1% | 0.00% | -100.0% |
Q3 2021 | $3,529,000 | -50.3% | 1,082,518 | -3.7% | 0.00% | 0.0% |
Q2 2021 | $7,104,000 | +2214.0% | 1,123,852 | +671.6% | 0.00% | – |
Q1 2021 | $307,000 | +2970.0% | 145,648 | +1258.5% | 0.00% | – |
Q4 2020 | $10,000 | -61.5% | 10,721 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | -36.6% | 10,721 | 0.0% | 0.00% | – |
Q2 2020 | $41,000 | +141.2% | 10,721 | -14.4% | 0.00% | – |
Q1 2020 | $17,000 | -15.0% | 12,529 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | -20.0% | 12,529 | 0.0% | 0.00% | – |
Q3 2019 | $25,000 | – | 12,529 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
Virtu Financial LLC | 80,728 | $59 | 0.01% |
Renaissance Technologies | 1,242,370 | $915 | 0.00% |
LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
Caption Management, LLC | 75,000 | $55,238 | 0.00% |
J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |